BOSTON–(BUSINESS WIRE)–Cerevance, a drug discovery and development company focused on brain diseases, today announced that Rudolph Tanzi, Ph.D., has joined the company as a senior-level scientific advisor. Dr. Tanzi is the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard University and …
Source: BioSpace